The US pharmaceutical company announced that it is starting a new phase 3 trial. Up to 30,000 people will enroll in the new global trial, the company said in a statement.
Learn more details here.
11/17/2020, 12:36:56 AM
The US pharmaceutical company announced that it is starting a new phase 3 trial. Up to 30,000 people will enroll in the new global trial, it said | Economy | CNN
The US pharmaceutical company announced that it is starting a new phase 3 trial. Up to 30,000 people will enroll in the new global trial, the company said in a statement.
Learn more details here.